United States · Series E startup

Who invested in Circle Pharma

4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$187Mraised across 4 rounds since 2014, from 4 sources

$4.5MSeries A$90MSeries D$93MSeries E
Latest round
Series E, $93MSept 2026
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014201620182020202220242026
?Seed$4.5MSeries A$90MSeries D$93MSeries E
First round
Seed
Sept 2014
Biggest round
$93M
Series E · Sept 2026
Usual gap between rounds
2.3 years
the median of 3

The rounds

  1. Sept 2026
    Series E$93M1 new1 returning

    Source recorded

  2. Sept 2024
    Series D$90M2 new

    Source recordedSEC filing: $63M sold, first sale Jun 2024

  3. Dec 2016
    Series A$4.5M1 returning

    Reported by FinSMEsSEC filing: $3.8M sold, first sale Sept 2016

  4. Sept 2014
    SeedAmount undisclosed2 new

    From a historical funding record

Founders and team

From Circle Pharma's own website: 9 on the team.

  • Bryan M. LentChief Financial Officer
  • Rob LauzenChief Financial Officer
  • Carlos ChavezExecutive Director, Head of Facilities and Research Operations
  • David DiazExecutive Director, Head of DMPK/ Clinical Pharmacology/Toxicology
  • Denise PosadaExecutive Director, Head of Data Management
  • Carolina RyklanskyDirector, Clinical Scientist
  • Jinshu FangAssociate Director, DMPK/Clinical Pharmacology/Toxicology
  • Luis HernandezAssociate Director, Research Operations
  • Stacey MendozaManager, HR Operations

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Eli LillyCorporate VC2rounds
Mission Bay CapitalVC firm2rounds
RA Capital ManagementPrivate equity1round
PfizerCorporate VC1round
Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Circle Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

The Column GroupVC firmPer its own site
Nextech InvestPrivate equityPer its own site
Lifeforce CapitalVC firmPer its own site
Berkeley Catalyst FundVC firmPer its own site

Quick answers about Circle Pharma

Who invested in Circle Pharma?

Circle Pharma's investors include Eli Lilly, Mission Bay Capital, RA Capital Management, Pfizer and Mission BioCapital.

How much has Circle Pharma raised?

Circle Pharma has raised $187M across 4 rounds since 2014. One round did not disclose an amount, so the total is a floor.

When did Circle Pharma last raise?

Circle Pharma's most recent round was a Series E of $93M in Sept 2026.

What was Circle Pharma's biggest round?

Its most recent round, $93M in Sept 2026, is also its largest on record.

Who backed Circle Pharma first?

Circle Pharma's first round on record, in Sept 2014, was backed by Pfizer and Mission Bay Capital.

What stage is Circle Pharma at?

Circle Pharma's latest named round is a Series E, in Sept 2026.

Where is Circle Pharma based?

Circle Pharma is based in the United States.

Companies like Circle Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.